Amgen Inc. buy Scotiabank
Start price
13.11.25
/
50%
€292.00
Target price
13.11.26
€332.22
Performance (%)
-2.92%
Price
23.12.25
€281.10
Summary
This prediction is currently active. With a performance of -2.92%, the BUY prediction by Scotiabank is trending in the wrong direction. A total of €2.38 was paid as dividends for this prediction. This prediction currently runs until 13.11.26. The prediction end date can be changed by Scotiabank at any time. Scotiabank has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 1.206% | 1.206% |
| iShares Core DAX® | 1.732% | 4.638% |
| iShares Nasdaq 100 | 3.304% | 0.517% |
| iShares Nikkei 225® | 2.342% | 0.972% |
| iShares S&P 500 | 2.357% | 0.872% |
Comments by Scotiabank for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) is now covered by analysts at Scotiabank. They set an "outperform" rating and a $385.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat